scispace - formally typeset
T

Tasha M. Burwinkle

Researcher at University of Washington

Publications -  31
Citations -  8614

Tasha M. Burwinkle is an academic researcher from University of Washington. The author has contributed to research in topics: Quality of life & Chronic pain. The author has an hindex of 24, co-authored 31 publications receiving 7886 citations.

Papers
More filters
Journal ArticleDOI

The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity.

TL;DR: The results demonstrate the feasibility, reliability, and validity of the PedsQLTM 4.0 Generic Core Scales as a school population health measure for children and adolescents.
Journal ArticleDOI

The PedsQL™ in Pediatric Asthma: Reliability and Validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Asthma Module

TL;DR: The results demonstrate the reliability, validity, and responsiveness of the PedsQL™ required for an outcome measure in pediatric asthma clinical trials and research.
Journal Article

The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity.

TL;DR: The PedsQL Multidimensional Fatigue Scale distinguished between healthy children and children with rheumatic diseases as a group, and was associated with greater disease severity.
Journal ArticleDOI

The PedsQL: reliability and validity of the short-form generic core scales and Asthma Module.

TL;DR: The PedsQL™ 4.0 SF15 and the Asthma Symptoms scale and Treatment Problems scale from the Pedsql™ 3.0SF22 Asthma Module demonstrated the best reliability and validity and should be suitable for group-level comparisons of generic and asthma-specific HRQoL in clinical research studies of children with asthma.
Journal ArticleDOI

Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia.

TL;DR: Pediatric patients with brain tumors are often excluded from health‐related quality of life studies even though they experience more severe disease and treatment‐related sequelae than children with other types of cancer.